Cabergoline is associated with hyperprolactinemia (high levels of prolactin, a natural substance that helps breastfeeding women produce breast milk, can cause symptoms such as infertility, sexual problems, and bone loss in non-breastfeeding women or men. Yes) used to treat. Cabergoline market size is projected to reach US$ 9 million by 2027, from US$ 7 million […]
